Skip to main content
NIPPON KAYAKU CO.,LTD. logo

NIPPON KAYAKU CO.,LTD. — Investor Relations & Filings

Ticker · 4272 ISIN · JP3694400007 T Manufacturing
Filings indexed 98 across all filing types
Latest filing 2026-06-04 Transaction in Own Shar…
Country JP Japan
Listing T 4272

About NIPPON KAYAKU CO.,LTD.

https://www.nipponkayaku.co.jp/english/

Nippon Kayaku Co., Ltd. is a diversified chemical manufacturer operating through four primary business segments: Functional Chemicals, Pharmaceuticals, Safety Systems, and Agrochemicals. The Functional Chemicals division produces materials such as high-purity epoxy resins for the electrical and electronic fields, as well as dyestuffs. The Pharmaceuticals business focuses on specialty areas, including cancer-related drugs and cardiovascular treatments. Leveraging its historical expertise in explosives, the Safety Systems division develops and manufactures critical automotive safety components like airbag inflators. The company also provides a range of agrochemical products. Guided by its corporate slogan, "Global 'sukima' ideas," Nippon Kayaku aims to be a leading provider in niche global markets by developing unique technologies and products.

Recent filings

Filing Released Lang Actions
自己株式の取得状況に関するお知らせ
Transaction in Own Shares Classification · 95% confidence The document is an announcement of the company’s own share acquisition (buy-back) under the Companies Act, detailing number of shares purchased, purchase period and amount. This clearly fits the “Transaction in Own Shares (share repurchase)” category.
2026-06-04 Japanese
Notice regarding Acquisition of Treasury Stock Results
Transaction in Own Shares Classification · 95% confidence The document is a notice of results for the acquisition of treasury stock, detailing the number of shares repurchased, total cost, period, and method. This type of announcement fits the definition of a share buyback or transaction in own shares. Therefore, it should be classified under Transaction in Own Shares (Code: POS).
2026-06-04 English
「ゾラデックス3.6mgデポ/LA10.8mgデポ」の製造販売承認 承継に関する契約を締結
Regulatory Filings Classification · 80% confidence The document is a timely disclosure announcing that Nippon Kayaku Co., Ltd. has entered into a contract to succeed the manufacturing and marketing approval for a pharmaceutical product (“Zoladex®”) from AstraZeneca. It is a business agreement announcement rather than a financial report, management change, M&A, earnings release, or other specific filing type. It does not contain financial statements or voting information, nor is it a report publication or proxy. Therefore, it falls under the general regulatory announcement / miscellaneous category (RNS).
2026-05-25 Japanese
臨時報告書
Regulatory Filings Classification · 90% confidence The document is a Japanese 臨時報告書 (“extraordinary report”) filed under the Financial Instruments and Exchange Act, providing ad hoc disclosure of a material event (receipt of dividend from a subsidiary). It is not an annual or interim report, earnings release, management presentation, or any of the other specific categories. It is a standalone regulatory filing disclosing a material event, so it falls into the fallback category of Regulatory Filings (RNS).
2026-05-13 Japanese
連結子会社からの配当金受領に関するお知らせ
Regulatory Filings Classification · 85% confidence The document is a brief corporate disclosure dated May 13, 2026 by Nippon Kayaku detailing receipt of dividend income from a consolidated subsidiary. It contains no financial statements, strategic presentation, or meeting materials, nor is it a shareholder dividend distribution notice. It is a standard Japanese investor/regulatory announcement. It does not fit into any specific ‘dividend payout’ category (DIV is for dividends paid to shareholders), nor financing, share issuance, or share repurchase categories. Therefore it falls into the fallback Regulatory Filings category (RNS).
2026-05-13 Japanese
2026年3月期 決算短信〔日本基準〕(連結)
Earnings Release Classification · 90% confidence The document is a Japanese “決算短信” (“Kessan Tanshin”), which is the company’s official financial results announcement for the fiscal year ended March 31, 2026. It contains actual financial highlights, summary tables of performance, cash flows, forecasts, and dividend information, but explicitly states it is unaudited (“決算短信は公認会計士又は監査法人の監査の対象外です”). It is not a full annual report (10-K) but rather the initial earnings release of periodical financial results. Therefore, it should be classified as an Earnings Release (Code: ER). FY 2026
2026-05-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.